Fig. 3From: Valsartan reduces NOX4 expression and halts diabetic nephropathy in streptozotocin induced diabetic rat modelRenal tissue stained with H&E (5 mm). a GpI: normal group. b–d GpII: diabetic nephropathy group. e, f GpIII: valsartan-treated groupBack to article page